Product category:
Proteomics
News Release from: Protagen
Edited by the Laboratorytalk Editorial
Team on 13 December 2007
Distribution agreement for Modiro in
Japan
Protagen has entered into a distribution agreement for its bio-IT software product, Modiro - the PTM-Explorer with Tomy Digital Biology of Tokyo, Japan.
Modiro was launched in the market in March 2007, and the initial sales figures have demonstrated how valuable first-class software for the qualitative analysis of post-translational modifications (PTMs) is to protein researchers Protagen has been successful in positioning Modiro in both Europe and the USA, and expects increasing sales of the product in these markets
This article was originally published on Laboratorytalk on 8 Mar 2007 at 8.00am (UK)
Related stories
Modiro analyses post-translational modifications
Protagen, a provider of products, services and software for protein research, has launched its new Bio-IT software product Modiro PTM-Explorer for analysis of protein post-translational modifications
GMP protein analysis services launched by Protagen
Protagen has recently completed a programme of work under GMP for Nordmark Pharma, Hamburg and will now introduce the GMP services to a wider circle of pharmaceutical customers
Developing antibodies against liver proteins
Unichip products of Protagen are versatile research tools that enable faster antibody development by rapidly identifying the most specific antibody candidates at an early stage of development
Through this agreement with Tomy Digital Biology, Protagen will gain an established distributor for the commercialisation of its product in the Japanese market.
Tomy Digital Biology has been established for over 40 years and has a good reputation among Japan's researchers, supplying research institutes such as the Riken-Brain Institute and the Osaka National Research Institute.
The exclusive rights for distribution of Modiro in Japan granted to Tomy Digital Biology will help to secure its leading position as a professional provider of bio-IT software and associated products.
Post-translational protein modifications modulate the activity of many proteins and the analysis of these changes is of growing importance in the research and development of new drug candidates.
Modiro enables researchers to identify significantly more of these critical modifications using existing mass-spectrometry data.
In addition, by automating the identification of PTMs, the PTM-Explorer reduces the time needed for protein analysis.
Christoph Huls, CEO of Protagen, said: "The signing of this commercialisation agreement demonstrates the continued advance of Protagen into the Asian market, which began with the research collaboration with Kangdi Antibody Biotech and Bejing Proteome Research Centre announced earlier this year.".
• Protagen: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
